NCT00428701View on ClinicalTrials.gov

An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Gastric Ulcer
Interventions
DRUG

Esomeprazole Sodium

Trial Locations (5)

Unknown

Research SIte, Newark

Research Site, Shreveport

Research Site, Hershey

Research Site, Memphis

Research Site, Nashville

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00428701 - An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium | Biotech Hunter | Biotech Hunter